Dr. Jay Dinerman
Claim this profileHeart Center Research
Studies Heart Failure
Studies Congestive Heart Failure
3 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Jay Dinerman is currently running
Defibrillator Lead
for Rapid Heartbeat
The LEADR study is designed to assess the safety and efficacy of the Next Generation ICD lead. The LEADR LBBAP study is being conducted under the existing US FDA Investigational Device Exemption (IDE) for the Next Generation ICD Lead and is designed to confirm the safety and defibrillation efficacy of the Next Generation ICD Lead when placed in the LBBAP location in ICD and LOT-CRT patient population.
Recruiting1 award N/A5 criteria
Diuretics vs Afterload Reduction
for Congestive Heart Failure
The DART-HA study is a single-center, open label, trial intended to evaluate the clinical efficacy of standard treatment options for congestive heart failure (observation, diuretic or afterload reduction therapy) in patients without new symptoms who have developed abnormalities of the HeartLogic heart failure diagnostic feature.
Recruiting3 awards Phase 4
More about Jay Dinerman
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jay Dinerman has experience with
- Bumetanide
- Furosemide
- Hydralazine
- Isosorbide Dinitrate
- Sacubitril/valsartan
- Torsemide
Breakdown of trials Jay Dinerman has run
Congestive Heart Failure
Tachycardia
Tachyarrhythmias
Sudden Death
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jay Dinerman specialize in?
Jay Dinerman focuses on Heart Failure and Congestive Heart Failure. In particular, much of their work with Heart Failure has involved treating patients, or patients who are undergoing treatment.
Is Jay Dinerman currently recruiting for clinical trials?
Yes, Jay Dinerman is currently recruiting for 2 clinical trials in Huntsville Alabama. If you're interested in participating, you should apply.
Are there any treatments that Jay Dinerman has studied deeply?
Yes, Jay Dinerman has studied treatments such as Bumetanide, Furosemide, Hydralazine.
What is the best way to schedule an appointment with Jay Dinerman?
Apply for one of the trials that Jay Dinerman is conducting.
What is the office address of Jay Dinerman?
The office of Jay Dinerman is located at: Heart Center Research, Huntsville, Alabama 35801 United States. This is the address for their practice at the Heart Center Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.